Table 1 Demographic characteristics of HIV-infected drug-naïve Moroccan patients at the time of the sampling (during the period 2009–2015)
Characteristic | Number (80) | Frequency % | Descriptive statistic | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mean | s2 | SD | Med | CV (%) | SE | Q1 | Q3 | IQR | Range | |||
Sex | 40.00 | 484.00 | 22.00 | 40.00 | 0.550 | 22.00 | 29.00 | 51.00 | 22.00 | 44.00 | ||
Men | 62 | 77.5 | ||||||||||
Women | 18 | 22.5 | ||||||||||
Age category (years) | ||||||||||||
< 11 | 4 | 5 | 37.075 | 166.019 | 12.88 | 36 | 0.348 | 1.45 | 31 | 45.25 | 14.25 | 85 |
11–24 | 4 | 5 | ||||||||||
25–44 | 49 | 61.25 | ||||||||||
> 44 | 23 | 28.75 | ||||||||||
Transmission route | ||||||||||||
Heterosexual contact | 65 | 81.25 | 20.00 | 340.50 | 18.45 | 13.50 | 0.923 | 10.654 | 4.00 | 29.500 | 25.50 | 45.00 |
Mother to child | 4 | 5 | ||||||||||
Not determined | 11 | 13.75 | ||||||||||
CDC category at HIV diagnosis | ||||||||||||
Class A | 28 | 35 | 20.00 | 31.50 | 5.612 | 19.50 | 0.281 | 3.240 | 16.00 | 23.500 | 7.50 | 15.00 |
Class B | 13 | 16.25 | ||||||||||
Class C | 17 | 21.25 | ||||||||||
Not determined | 22 | 27.5 | ||||||||||
CD4 cell count category (cells/ml) | ||||||||||||
0–49 | 3 | 3.75 | 388.59 | 32,570.27 | 180.47 | 409 | 0.464 | 23.107 | 285.25 | 506 | 220.75 | 780 |
50–99 | 4 | 5 | ||||||||||
100–199 | 6 | 7.5 | ||||||||||
200–349 | 8 | 10 | ||||||||||
≥ 350 | 41 | 51.25 | ||||||||||
Not determined | 18 | 22.5 | ||||||||||
Viral load category (copie/ml) | ||||||||||||
< 249 | 2 | 2.5 | 3.8E+05 | 7.9E+11 | 8.9E+05 | 9.6E+04 | 2.3E+00 | 1.1E+05 | 2.9E+04 | 2.6E+05 | 2.3E+05 | 5.6E+06 |
250–4999 | 5 | 6.25 | ||||||||||
5000–29,999 | 10 | 12.5 | ||||||||||
30,000–99,999 | 15 | 18.75 | ||||||||||
100,000–999,000 | 25 | 31.25 | ||||||||||
≥ 1000,000 | 7 | 8.75 | ||||||||||
Not determined | 16 | 20 | ||||||||||